Inhibitory effect of novel tetrahydropyrimidine-2(1H)-thiones on melanogenesis.
暂无分享,去创建一个
Sang-Hun Jung | Seong-Cheol Bang | Jee-Hyun Lee | B. Hwang | Youngsoo Kim | Eunmiri Roh | Youngsoo Kim | P Thanigaimalai | Ki-Cheul Lee | Cheong-Yong Yun | Bang-Yeon Hwang | Sang-hun Jung | P. Thanigaimalai | Ki-Cheul Lee | Seong-Cheol Bang | E. Roh | Cheong-Yong Yun | Jee-Hyun Lee
[1] K. Kawai,et al. Contact allergy to kojic acid in skin care products , 1995, Contact dermatitis.
[2] Y. Mishima. Molecular and biological control of melanogenesis through tyrosinase genes and intrinsic and extrinsic regulatory factors. , 1994, Pigment cell research.
[3] M. Fukuda,et al. Arbutin: mechanism of its depigmenting action in human melanocyte culture. , 1996, The Journal of pharmacology and experimental therapeutics.
[4] F. García-Cánovas,et al. Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. , 1993, The Biochemical journal.
[5] G. Prota. Progress in the chemistry of melanins and related metabolites , 1988, Medicinal research reviews.
[6] Francisco Solano,et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.
[7] M. Miranda,et al. Inhibition of L-tyrosine-induced micronuclei production by phenylthiourea in human melanoma cells. , 1999, Mutation research.
[8] M. Cava,et al. Thionation reactions of lawesson's reagents , 1985 .
[9] V. Hearing,et al. Mammalian tyrosinase--the critical regulatory control point in melanocyte pigmentation. , 1987, The International journal of biochemistry.
[10] E. Monzani,et al. Inhibition of the catecholase activity of biomimetic dinuclear copper complexes by kojic acid , 2000, JBIC Journal of Biological Inorganic Chemistry.
[11] K. Wakamatsu,et al. Eumelanin biosynthesis is regulated by coordinate expression of tyrosinase and tyrosinase-related protein-1 genes. , 1993, Experimental cell research.
[12] C. Dardonville,et al. Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the mu-opioid receptor and I2-imidazoline binding sites. , 2006, Bioorganic & medicinal chemistry.
[13] E. Berardesca,et al. Clinical and Instrumental Evaluation of Skin Improvement after Treatment with a New 50% Pyruvic Acid Peel , 2006, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[14] Youngsoo Kim,et al. Oxyresveratrol and Hydroxystilbene Compounds , 2002, The Journal of Biological Chemistry.
[15] Tetsuro Ito,et al. Inhibitory Effects of Resveratrol Derivatives from Dipterocarpaceae Plants on Tyrosinase Activity , 2003, Bioscience, biotechnology, and biochemistry.
[16] H. Glatt,et al. Inhibitors of mammalian melanocyte tyrosinase: in vitro comparisons of alkyl esters of gentisic acid with other putative inhibitors. , 1999, Biochemical pharmacology.
[17] S. H. Kang,et al. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. , 1998, Biochemical and biophysical research communications.
[18] S. Orlow,et al. Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. , 2005, Pigment cell research.
[19] S. Passi,et al. Molecular basis of substrate and inhibitory specificity of tyrosinase: phenolic compounds , 1981, The British journal of dermatology.
[20] Ikuko Miyazaki,et al. Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease , 2009, Neurotoxicity Research.
[21] Marc Criton,et al. Analogues of N-hydroxy-N'-phenylthiourea and N-hydroxy-N'-phenylurea as inhibitors of tyrosinase and melanin formation. , 2008, Bioorganic & medicinal chemistry letters.
[22] K. Vrana,et al. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase , 1998, Journal of neuroscience research.
[23] Piotr Prokopowicz,et al. Effective and mild method for preparation of optically active α-amino aldehydes via TEMPO oxidation , 1998 .